Cerner and Claritas Genomics Will Collaborate to Advance Personalized Medicine

FOR IMMEDIATE RELEASE Dec 5, 2013 KANSAS CITY, Mo. and CAMBRIDGE, Mass., Dec 05, 2013 (GLOBE NEWSWIRE via COMTEX) — Cerner Corp. CERN -0.14% and Claritas Genomics announce that the companies will work together to advance personalized medicine by building tools and connectivity that will better integrate next generation sequence (NGS)-based diagnostic testing into health […]

Cincinnati Children’s Joins Boston Children’s to Establish the Claritas Pediatric Genomic Network

FOR IMMEDIATE RELEASE Nov 12, 2013 Pediatric hospitals to share data and genomic testing infrastructure for the benefit of patients Cambridge, Nov 12— Cincinnati Children’s Medical Center has partnered with Claritas Genomics, a company formed by Boston Children’s Hospital and Life Technologies Corporation (NASDAQ: LIFE), to provide genomics-based diagnostics for pediatric patients. Cincinnati Children’s will work […]

Claritas Genomics to Sequence 18,000 Exomes for the Million Veterans Program with Ion Torrent Next-Generation Sequencers

As reported in the Wall Street Journal BOSTON, October 21, 2013 /PRNewswire/ – Claritas Genomics, together with partners Life Technologies (NASDAQ: LIFE) and Lockheed Martin (NYSE: LMT), announced today that the Veterans Administration (VA) has awarded Claritas a contract to sequence the exomes of 18,000 military veterans over the next 12 months, one of the largest sequencing […]

Boston Children’s Hospital and Life Technologies Launch Claritas Genomics, a Clinical Genomics Company

January 8, 2013 Spinoff venture will develop genomic sequencing solutions utilizing Ion Torrent technology for clinical applications SAN FRANCISCO, Jan. 8, 2013 /PRNewswire-USNewswire/ – Boston Children’s Hospital has partnered with Life Technologies Corporation(NASDAQ: LIFE) to launch Claritas Genomics, a new company formed to develop next-generation, genetic and genomics-based diagnostic testing solutions. The venture combines advanced instrumentation, software and bioinformatics capabilities with sophisticated clinical […]